![Mark Brian Anderson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Brian Anderson
No open positions remaining
Profile
Mark Brian Anderson worked as a Director-Medicinal Chemistry at Agouron Pharmaceuticals LLC and Pfizer (La Jolla) from 1997 to 2002.
He also worked as a Senior Director at Elitra Pharmaceuticals, Inc. in 2003.
Anderson was a Senior Scientist at Glycomed, Inc. and Ligand Pharmaceuticals, Inc. He served as Vice President at Myriad Genetics, Inc. and Myrexis, Inc. from 2003 to 2009.
Anderson was also the Chief Scientific Officer at NovaBay Pharmaceuticals, Inc. and Biotech Pharmacy, Inc. Anderson holds a doctorate from Purdue University and an undergraduate degree from the University of Minnesota.
Former positions of Mark Brian Anderson
| Companies | Position | End |
|---|---|---|
Biotech Pharmacy, Inc.
 Biotech Pharmacy, Inc. Medical DistributorsDistribution Services Supplies medical equipment | Chief Tech/Sci/R&D Officer | 01/10/2009 |
| MYRIAD GENETICS, INC. | Corporate Officer/Principal | 01/03/2009 |
| MYREXIS, INC. | Corporate Officer/Principal | 01/03/2009 |
Elitra Pharmaceuticals, Inc.
 Elitra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Director/Board Member | 01/11/2003 |
Agouron Pharmaceuticals LLC
 Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and distributes therapeutic products | Corporate Officer/Principal | 01/06/2002 |
Training of Mark Brian Anderson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
35
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and distributes therapeutic products | Health Technology |
Glycomed, Inc.
 Glycomed, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops pharmaceuticals based on complex carbohydrates | Health Technology |
Ligand Pharmaceuticals, Inc.
 Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies | Health Technology |
Myriad Genetics, Inc.
 Myriad Genetics, Inc. Medical SpecialtiesHealth Technology Develops therapeutic and predictive medicine products | Health Technology |
Elitra Pharmaceuticals, Inc.
Elitra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
NovaBay Pharmaceuticals, Inc.
 NovaBay Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and sale of eye and wound care products | Health Technology |
Myrexis, Inc.
 Myrexis, Inc. Financial ConglomeratesFinance Engages in identifying, evaluating and making financial investments in life sciences assets | Finance |
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biotech Pharmacy, Inc.
Biotech Pharmacy, Inc. Medical DistributorsDistribution Services Supplies medical equipment | Distribution Services |
Pfizer (La Jolla)
 Pfizer (La Jolla) Miscellaneous Commercial ServicesCommercial Services Provides research services | Commercial Services |
- Stock Market
- Insiders
- Mark Brian Anderson
